Johnson & Johnson
(NYSE) JNJ
Johnson & Johnson Financials at a Glance
Market Cap
$567.22B
Revenue (TTM)
$94.19B
Net Income (TTM)
$26.80B
EPS (TTM)
$11.05
P/E Ratio
21.31
Dividend
$5.20
Beta (Volatility)
0.20 (Low)
Dividend
$5.20
Beta (Volatility)
0.20 (Low)
Price
$235.79
Volume
369,368
Open
$237.15
Price
$235.79
Volume
369,368
Open
$237.15
Previous Close
$235.79
Daily Range
$234.61 - $238.49
52-Week Range
$141.50 - $251.71
Dividend
$5.20
Beta (Volatility)
0.20 (Low)
Price
$235.79
Volume
369,368
Open
$237.15
Previous Close
$235.79
Daily Range
$234.61 - $238.49
52-Week Range
$141.50 - $251.71
JNJ News
Dividend Kings of 2026
Best Blue Chip ETFs to Buy in 2026
JNJ: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Johnson & Johnson
Industry
Pharmaceuticals
Sector
Health CareEmployees
140,800
CEO
Joaquin Duato, MBA
Website
www.jnj.comHeadquarters
New Brunswick, NJ 08933, US
JNJ Financials
Key Financial Metrics (TTM)
Gross Margin
73%
Operating Margin
27%
Net Income Margin
28%
Return on Equity
35%
Return on Capital
18%
Return on Assets
13%
Earnings Yield
4.69%
Dividend Yield
0.02%
Payout Ratio
46.19%
Stock Overview
Market Cap
$567.22B
Shares Outstanding
2.41B
Volume
369.37K
Short Interest
0.00%
Avg. Volume
8.61M
Financials (TTM)
Gross Profit
$68.56B
Operating Income
$25.60B
EBITDA
$39.90B
Operating Cash Flow
$24.53B
Capital Expenditure
$4.83B
Free Cash Flow
$19.70B
Cash & ST Invst.
$20.10B
Total Debt
$47.93B
Johnson & Johnson Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$24.56B
+9.1%
Gross Profit
$21.22B
+37.8%
Gross Margin
86.37%
N/A
Market Cap
$567.22B
N/A
Market Cap/Employee
$4.11M
N/A
Employees
138,100
N/A
Net Income
$5.12B
+49.1%
EBITDA
$6.21B
+4.9%
Quarterly Fundamentals
Net Cash
$27.83B
-129.8%
Accounts Receivable
$17.18B
-9.2%
Inventory
$14.19B
+14.0%
Long Term Debt
$39.44B
+28.7%
Short Term Debt
$8.49B
+42.0%
Return on Assets
13.46%
N/A
Return on Invested Capital
17.64%
N/A
Free Cash Flow
$5.47B
+13.1%
Operating Cash Flow
$7.31B
+4.7%